Charles S. Berkman
2007 - Ligand Pharmaceuticals
In 2007, Charles S. Berkman earned a total compensation of $395.1K as Vice President and General Counsel at Ligand Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $87,734 |
|---|---|
| Option Awards | $50,082 |
| Salary | $230,878 |
| Stock Awards | $23,935 |
| Other | $2,446 |
| Total | $395,075 |
Berkman received $230.9K in salary, accounting for 58% of the total pay in 2007.
Berkman also received $87.7K in non-equity incentive plan, $50.1K in option awards, $23.9K in stock awards and $2.4K in other compensation.
Rankings
In 2007, Charles S. Berkman's compensation ranked 6,764th out of 8,700 executives tracked by ExecPay. In other words, Berkman earned more than 22.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,764 out of 8,700 | 22nd |
Division Manufacturing | 2,588 out of 3,314 | 22nd |
Major group Chemicals And Allied Products | 586 out of 746 | 21st |
Industry group Drugs | 417 out of 546 | 24th |
Industry Pharmaceutical Preparations | 296 out of 364 | 19th |
Source: SEC filing on April 29, 2009.
Berkman's colleagues
We found four more compensation records of executives who worked with Charles S. Berkman at Ligand Pharmaceuticals in 2007.
2007
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2007
Zofia Dziewanowska
Ligand Pharmaceuticals
Vice President, Clinical Research and Regulatory
2007
Martin Meglasson
Ligand Pharmaceuticals
Vice President, Discovery Research
2007
John Sharp
Ligand Pharmaceuticals